Betta Pharmaceuticals Secures Exclusive Rights to C4 Therapeutics’ CFT8919 in Greater China
China-based Betta Pharmaceuticals Co., Ltd (SHE: 300558) has announced an exclusive licensing agreement with US...
China-based Betta Pharmaceuticals Co., Ltd (SHE: 300558) has announced an exclusive licensing agreement with US...
China-based Lynk Pharmaceuticals Co., Ltd has successfully raised RMB 200 million (USD 28.3 million) through...
Wayne Shi, president of France-based Sanofi’s (NASDAQ: SNY) Greater China business, has been discussing the...
Boyi Biotech, a prominent biological microspheres developer headquartered in Changzhou, has reportedly secured more than...
Shanghai-based Zelixir Biotech, a leading provider of protein structure prediction and design services, has reportedly...
PathoAI, a company at the forefront of intelligent pathology and examination through artificial intelligence (AI),...
China-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) has revealed that its subsidiary,...
Shanghai-based medical device giant MicroPort Scientific Corp. (HKG: 0853) has announced its intention to spin...
Coherent Biopharma Ltd, a specialist in bispecific-ligand drug conjugates (Bi-XDC) headquartered in Suzhou, has declared...
Drug Farm, a Sino-US biotech company specializing in hepatitis B virus (HBV) treatments, oncology, and...
ExoRNA Bio, a Shenzhen-based central nervous system (CNS) drug developer, has reportedly raised tens of...
First Condor Biotechnology, a Guangdong-based cell therapy developer, has reportedly secured tens of millions of...
Angio8, a Shenzhen-based developer of vascular interventional surgical robots, has reportedly raised tens of millions...
China-based gene therapy developer Lingyi Biotechnology Co., Ltd has reportedly raised close to RMB 100...
China’s VivaVision Biotech Inc. has announced the successful completion of its Series D2 financing round,...
NeuExcell Therapeutics, a Sino-US biotech company specializing in treatments for neurological damage and degenerative diseases,...
Several multinational companies (MNCs) have released their Q1 2023 financials, showing a varied performance over...
Reforgene Medicine, a Guangzhou-based gene editing therapy company, has reportedly secured hundreds of millions of...
Roche (SWX: ROG), the Swiss pharmaceutical and diagnostics giant, reported a 3% year-on-year (YOY) decrease...
Dizal (Jiangsu) Pharmaceutical Co., Ltd (SHA: 688192), the China-based joint venture established by AstraZeneca (AZ,...